PATENT CLAIM ANALYSIS

Application Number: 15779753
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-09
Patent Classification: ["514", "04400A"]

Abstract:
The objective of the present invention is to provide a DNA aptamer that can specifically binding to a molecular targeted medicine, a composition comprising the DNA aptamer, and a method for detecting a molecular targeted medicine using the DNA aptamer. A DNA aptamer comprising specifically binding to a molecular targeted medicine, a composition for detecting a molecular targeted medicine comprising the DNA aptamer, a kid for detecting a molecular targeted medicine, and a method for detecting a molecular targeted medicine comprising using the DNA aptamer.

Claim (Index 15):
The method for detecting according to  claim 14 , comprising contacting the DNA aptamer with a sample obtained from a living body selected from a group consisting of blood, blood serum, blood plasma, saliva, and sputum, and detecting the presence of the molecular targeted medicine by observing the response caused by the binding of the sample and the DNA aptamer.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 3.06667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15563313', '12305102', '14738337', '14239012', '15524093']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7532932401775183
- 35 USC 102 Novelty (BERT): 0.506854360400882
- Combined Prediction Score: 0.7286493521998547
- Mean Citation Score: 247.399342
- Max Citation Score: 272.6006
- Similarity Product: 195.7079101867199

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test